All Posts By

Emily Lynch-Fries

SOCU 2022 Virtual Workshops

By | Uncategorized | No Comments

Skin of Color Update Virtual Workshops are an opportunity to attend complimentary sessions featuring trending evidence-based research and new practical pearls for treating skin types III – VI.

You do not need to be registered for Skin of Color Update 2022 to attend these free virtual workshops, however, pre-registration for each webinar is required.

Jae Yeon Jung, MD, PhD
Director, Oncologic Dermatology Program
Norton Cancer Institute

Supported By

Co-managing Patients with Locally Advanced Basal Cell Carcinoma (laBCC) and Advanced Cutaneous Squamous Cell Carcinoma (aCSCC) in the Immunotherapy Era: The Role of the Dermatologist

Wednesday, September 14th | 7:00 – 8:00 PM ET

Join Regeneron for a session to discuss:

  • An FDA-approved systemic treatment option
  • The important role of multidisciplinary consultation in the management of advanced CSCC and locally advanced BCC
  • Results and case studies from a prospective clinical study in locally advanced BCC patients
  • Updated results from a prospective clinical study in advanced CSCC patients
Register Here

Thank You to Incyte for Supporting Skin of Color Update 2021

By | Uncategorized | No Comments
New York (August 30, 2021) – Please take a moment to acknowledge and thank our gracious supporter, Incyte, by visiting their sponsor page on the Skin of Color Update 2021 Virtual Platform and Incyte.com.
Incyte is a global biopharmaceutical company that is focused on finding solutions for serious unmet medical needs through the discovery, development and commercialization of novel medicines.
Since 2002, Incyte has remained committed to the relentless pursuit of science that can improve the lives of patients, make a difference in healthcare and build sustainable value for our stakeholders. The Company is advancing a diversified portfolio of clinical candidates across Oncology and Inflammation & Autoimmunity. Our research and development efforts in Dermatology are focused on a number of immune-mediated dermatologic conditions with a high unmet medical need, including atopic dermatitis, vitiligo, and hidradenitis suppurativa.
Headquartered in Wilmington, Delaware, Incyte has operations in North America, Europe and Asia.
For more information, visit Incyte.com and follow @Incyte.